Keyphrases
Amikacin
12%
Antibiotic Concentration
12%
Antibiotic Efficacy
100%
Antibiotics
62%
Anticoagulants
25%
Bioassay System
12%
Catheter
12%
Catheter-related
25%
Catheter-related Infections
12%
Catheter-related Sepsis
100%
Central Venous Catheter
100%
Ciprofloxacin
37%
Clinical Trials
12%
Flucloxacillin
25%
Gentamicin
12%
Heparin
100%
Heparin Lock
100%
High Concentration
12%
High Dose
25%
In Vitro Stability
12%
In Vivo Efficacy
100%
Linezolid
25%
Lock Solution
100%
Major Risk
12%
Methicillin-resistant S. Aureus
12%
Methicillin-resistant Staphylococcus Aureus
12%
Microorganisms
12%
Number of Patients
12%
Prophylactic Use
12%
Pseudomonas Aeruginosa (P. aeruginosa)
12%
Septicemia
25%
Stable Solutions
12%
Taurolidine
25%
Teicoplanin
37%
Vancomycin-resistant Enterococci
12%
Medicine and Dentistry
Amikacin
10%
Antibiotics
20%
Antithrombotic
20%
Bioassay
10%
Catheter Infection
10%
Central Venous Catheter
100%
Ciprofloxacin
30%
Clinical Trial
10%
Drug Megadose
20%
Flucloxacillin
20%
Gentamicin
10%
Heparin
100%
In Vitro
100%
Infection
10%
Linezolid
20%
Methicillin Susceptible Staphylococcus Aureus
10%
Meticillin
10%
Pseudomonas aeruginosa
10%
Sepsis
100%
Septicemia
20%
Staphylococcus Aureus
10%
Taurolidine
20%
Teicoplanin
30%
Vancomycin Resistant Enterococcus
10%
Pharmacology, Toxicology and Pharmaceutical Science
Amikacin
10%
Antibiotics
20%
Anticoagulant Agent
20%
Catheter Infection
10%
Ciprofloxacin
30%
Clinical Trial
10%
Flucloxacillin
20%
Gentamicin
10%
Heparin
100%
Infection
10%
Linezolid
20%
Methicillin Susceptible Staphylococcus Aureus
10%
Meticillin
10%
Microorganism
10%
Pseudomonas aeruginosa
10%
Sepsis
100%
Septicemia
20%
Staphylococcus Aureus
10%
Taurolidine
20%
Teicoplanin
30%
Vancomycin-Resistant Enterococcus
10%
Immunology and Microbiology
Drug Megadose
25%
Methicillin Susceptible Staphylococcus Aureus
12%
Microorganism
12%
Pseudomonas aeruginosa
12%
Solution and Solubility
100%
Staphylococcus Aureus
12%
Vancomycin-Resistant Enterococcus
12%